Retatrutide Access Granted for Severe Obesity Patients Pre-Approval | Retatrutide News

Eli Lilly is offering pre-approval expanded access to retatrutide for adults with severe obesity. This access is for patients who cannot join ongoing tr...
Clinical Trials · November 2, 2026